Clinical Research and Its Relation with Improvements In Healthcare

Being a part of Healthcare sciences, Clinical Research determines the safety as well as effectiveness of medicines, diagnostic products, medical devices and treatment plans etc. which are intended for medical treatments of humans.  All these may be used to prevent, diagnose or treat the symptoms of diseases. Though clinical practice and clinical research are interrelated, both differ from each other. Diseases or ailments are treated using established treatments in clinical practices whereas clinical research includes the evidence that is collected in order to start treatment.

When a promising molecule or medicine is identified in the lab, then it is subjected to many pre-clinical and animal studies. Through this procedure, the effects and side effects or usage and toxicity of the test medicine is studied. Usually academic medical centers or affiliated research study sites carry out such Clinical research wherein they have access to large number of medical participants. The very ecosystem of Clinical research has grown more complex with the network of sites, numerous Pharma companies and research institutes. This in turn has created the need for new technologies in order to manage data, research and to perform clinical trials.

The Governance or Health authorities may need the evidence and authentication in order to use the resources required for research. Even the public understanding about the benefits of such researches is critical.

Required Infrastructure

Infrastructure refers to the health equipment, medical personal and patients, accommodation and so on in which the care is delivered. Clinical research activities demand lot of physical infrastructure like space, specialized equipment and resources to carry out the trials.

Another important aspect of infrastructure is the availability of specialized or experienced human resources in the field of medicine. Resources include physicians, scientists, nurses, laboratory experts, subject domain experts and other health professionals who have experience in the field of clinical research.

Such sophisticated infrastructure demands a huge investment capital and a good resource to manage the whole research unit.

Patient care

The processes involved in taking care of patients make a significant impact on the research outcomes. Such processes of care vary based on research-active and non-research active environments. Research-active institutions are more open for change and they readily receive continuous feedback from the processes. They usually follow the guidelines laid by the clinical practices and deploy new technologies to improve their patient care.

Potential Benefits of Clinical Research

Compared to the positive outcomes of Clinical research, negative clinical trials may be overlooked, even while taking into account of the associated costs and side effects. Such negative impacts are bound to happen and unavoidable while making new inventions to encounter more complex ailments like cancer.

Such clinical trials, often produce fruitful results which can be implemented to eradicate health epidemics or diseases or other ailments. Also, establishing such research units attract outstanding scientists and physicians who have the urge to discover new things in this field.

Phases of Clinical Research

The drugs or medications or therapies which are resulted from Clinical research are subjected to rigorous testing phases which are commonly classified into four phases. Each phase of the approval involves a cycle which is considered as a separate clinical trial and is monitored by highly experienced professionals in this field.  These clinical trials may take many years to go through the four phases in order to get an approval by the drug-development authorities. Extensive pre-clinical studies are conducted by the Pharma companies before they roll-out any medications or drugs.

The drugs or medications or therapies passes through the first three phases (say Phase 1, Phase 2 and Phase 3) then the National Regulatory Authority will approve it to be used among the general population. Phase 4 of this process includes the ‘post-approval’ monitoring and studies.

Conclusion

There is a need to analyze or measure the benefits associated with clinical research, which is right now not being done on a large scale. With the high costs associated with the clinical research, it is crucial to perform additional studies to analyze the impact of clinical research and its effectiveness in improving the patient care.